Rory McGowam is joined by Laurence Kemball-Cook, CEO & Founder of Pavegen. Laurence talks to Rory about how he has designed a system to convert our footsteps into electricity. With walkways popping up all over the UK and across the globe, could this be the solution to the energy crisis and a key tool in the fight against climate change?

https://www.pavegen.com/

https://www.crowdcube.com/companies/pavegen2/pitches/qD9yNl?_gl=1*1jyl4zg*_gcl_au*MTM0MTM3MzY3Ny4xNzUzNzgwMjEy

Rory McGowan is joined by Dan Harwood, a wine expert and strategiest. They discuss Gen Z's desire to go out but drink less. They also look at the shift in drinking in social situations and mindful drinking.

https://eisberg.co.uk/

Rory McGowan is joined by Craig Allan from ABAX. New research reveals how much of our workday is spent searching for misplaced items, rather than focusing on our job. Rory and Craig discuss this and more about all things tracking tech.

https://www.abax.com/en-gb

Rory McGowan is joined by TV chef, baker, and presenter Briony May Williams! You may recognise Briony from The Great British Bakeoff, Food Unwrapped, Morning Live and more! They discuss new research regarding Brits' ice cream habits, as well as some of Briony's tips and tricks for making your own at home.

https://www.cuisinart.co.uk/

Phil Jeynes, Head of Protection at MetLife UK, joins Rory McGowan in this episode. A new poll from accident & health protection experts MetLife UK has found that even in 2025, children still want mum when they’re ill or injured. It raises the question: how do women and families balance home and work life?

https://www.metlife.co.uk/

Rory McGowan is joined by Dr Olivia Ahn, co-founder of FLUUS and an expert in innovation and sustainability. With it being Climate Change Action Week, Dr Olivia talks about new research that shows a growing demand in sustainable period care.

https://wearefluus.com/

Rory McGowan is joined by Dr Juho Jalkanen from Faron Pharmaceuticals. In this episode they discuss a new blood cancer trial has shown highly promising results, particularly for patients who have relapsed or live with hard-to-treat forms of the disease.

https://faron.com/